VIEWPOINTS PharmaShots Interview: Artelo Bio’s Dr. Saoirse O’Sullivan Shares Insights on Synthetic Cannabinoid for Cancer AnorexiaBySenior EditorApril 23, 20210Comments
VIEWPOINTS PharmaShots Interview: Biogen’s Monica Mann Shares Insight on Plegridy to Treat Multiple SclerosisBySenior EditorApril 20, 20210Comments
VIEWPOINTS PharmaShots Interview: Codiak BioSciences’ Douglas E. Williams Shares Insight on the Potential of its Engineered ExosomesBySenior EditorApril 20, 20210Comments
VIEWPOINTS PharmaShots Interview: ViiV Healthcare’s Dr. Kimberly Smith Shares Insight on the Data Presented at CROI 2021BySenior EditorApril 19, 20210Comments
INSIGHTS+ Insights+: The US FDA New Drug Approvals in March 2021BySenior EditorApril 15, 20210Comments
VIEWPOINTS PharmaShots Interview: Leap Therapeutic’s Douglas Onsi Shares Insight on its Lead Candidate, DKN-01BySenior EditorApril 14, 20210Comments
VIEWPOINTS PharmaShots Interview: Fluxergy’s Tej Patel Shares Insight on Multimodal Diagnostic SystemBySenior EditorApril 13, 20210Comments
VIEWPOINTS PharmaShots Interview: Aravive’ s Dr. Gail McIntyre Shares Insight on AVB-500 and its Potential Against ccRCCBySenior EditorApril 9, 20210Comments
